The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

The three biggest pharmacy benefit managers marked up "lifesaving" medications to generate $7.3 billion in five years, ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments ...

A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.

Garth Reynolds, executive director of the Illinois Pharmacists Association, writes about what he calls a crisis related to ...